The bill amends K.S.A. 2024 Supp. 65-16,127 to exempt law enforcement agencies from the requirement to procure a physician medical director if they do not provide emergency opioid antagonists according to the statewide protocol. This change aims to streamline the process for law enforcement agencies that choose not to participate in the distribution of emergency opioid antagonists, thereby reducing administrative burdens. The bill also outlines the responsibilities of first responder agencies, healthcare providers, and pharmacists in relation to the dispensing and administration of emergency opioid antagonists, ensuring that they are trained and equipped to handle opioid overdose situations.

Additionally, the bill provides legal protections for healthcare providers, pharmacists, and individuals who administer emergency opioid antagonists in good faith, shielding them from civil liability or criminal prosecution, except in cases of gross negligence or willful misconduct. The state board of pharmacy is tasked with establishing a statewide opioid antagonist protocol that includes guidelines for recordkeeping, education, and emergency response procedures. The existing section of K.S.A. 2024 Supp. 65-16,127 is repealed, and the new provisions will take effect upon publication in the statute book.

Statutes affected:
As introduced: 65-16
Sub: 65-16